|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at BIO CEO & Investor Conference|
BOULDER, Colo., Feb. 10 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the BIO CEO & Investor Conference on February 24 in New York City.
Event: BIO CEO & Investor Conference Presentation: "The Early Bird Gets the Worm -- The Re-emergence of Pharma's Interest in Early Stage Compounds" Panelist: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Tuesday, February 24, 2004 Time: 11:00 a.m. Eastern Time Location: Waldorf-Astoria Hotel, New York City
About Array BioPharma:
Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes many promising small molecule drugs that affect disease pathways with well-validated targets. Array also collaborates with leading pharmaceutical and biotechnology companies to invent and optimize drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com .
SOURCE Array BioPharma Inc.